https://www.gosh.nhs.uk/news/north-thames-genomic-medicine-service-deputy-medical-director/
GOSH Consultant, Dr Emma Clement, joins the North Thames Genomic Medicine Service as Deputy Medical Director
12 Jan 2026, 10:56 a.m.
We are delighted to share that Dr Emma Clement has joined the North Thames Genomic Medicine Service (NT GMS) Deputy Medical Director. She joins the NT GMS senior team and will work alongside Medical Director, Dr Angela George, and COO, Anthony Sullivan, to deliver the genomics ambitions of the 10-Year Plan.
Dr Sophia Varadkar, GOSH Acting Chief Medical Officer and Acting Senior Responsible Officer for the NT GMS said: “We are absolutely delighted to welcome Dr Emma Clement as Deputy Medical Director for the North Thames Genomic Medicine Service, she brings with her fantastic experience of integrating genomics into routine clinical care which will be vital as the service continues to expand.”
Dr Clement has been a Consultant in Clinical Genetics and Genomic Medicine at GOSH since 2017 and played a significant role in the delivery of the 100,000 genomes project at the hospital. She has a specialist interest in paediatric rare disease, particularly in the genetics of hearing loss and dual sensory conditions.
Dr Angela George, NT GMS Medical Director said: "It is fantastic to have Dr Emma Clement joining our NT GMS team and I am excited to be working with her as we continue to build our service. Emma’s track record in embedding genomics into routine clinical care, alongside her leadership in education and paediatric rare disease, will be invaluable as we deliver our ambitions across North Thames and improve outcomes for patients."
Dr Clement brings a wealth of experience to the role, having worked closely with other clinical teams across GOSH to embed genomic sequencing into routine care.
Dr Emma Clement said: "I am really happy to be stepping into the role of Deputy Medical Director for the North Thames GMS. I'm looking forward to working collaboratively across our region to help embed genomics into routine patient care."
New trial to support childhood survivors of brain tumours
Experts at Great Ormond Street Hospital have launched the first trial of its kind to support children’s cognitive development following treatment for a brain tumour.
Professor Waseem Qasim named in list of leading global health leaders
Professor Waseem Qasim, Consultant at GOSH and Professor of Cell and Gene Therapy at University College London has been named in TIME magazine’s 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.
Alyssa Tapley named in list of leading global health leaders
GOSH patient, Alyssa Tapley, 17 from Leicester, has been named in TIME’S 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.
GOSH joins partnership to boost early diagnosis and deliver better treatments
GOSH is partnering with LifeArc to set up KidsRare - a new initiative to help deliver more tests and treatments for children living with a rare disease.